Reporting Organization: | WHO - World Health Organization |
---|---|
Total Budget ($CAD): | $ 15,000,000 |
Timeframe: | February 14, 2011 - December 31, 2012 |
Status: | Completion |
Contact Information: | Unspecified |
WHO - World Health Organization
Unspecified
Sub-Saharan Africa - $ 5,685,000.00 (37.90%) | |
|
|
Europe - $ 2,400,000.00 (16.00%) | |
|
|
Southeast Asia - $ 2,040,000.00 (13.60%) | |
|
|
South Asia - $ 1,695,000.00 (11.30%) | |
|
|
East Asia - $ 1,485,000.00 (9.90%) | |
|
|
Central Asia - $ 930,000.00 (6.20%) | |
|
|
North Africa - $ 765,000.00 (5.10%) | |
|
Infectious & Communicable Diseases (100 %) | |
|
This project aims to improve and strengthen surveillance and immunization systems through support to the Global Polio Eradication Initiative’s (GPEI’s) 2010-2012 Strategic Plan. The goal of the GPEI is to eradicate polio from the planet. CIDA’s support contributes to strategies within the plan to address sub-national gaps in surveillance sensitivity in three endemic regions, to ensure certification-standard surveillance is sustained in regions which are polio-free, and to enhance the effectiveness of outbreak response activities. It also contributes to strengthening immunization systems and increasing coverage rates of the full range of classical childhood vaccines, and/or assisting with the delivery of other important child survival interventions such as vitamin A, zinc supplementation and the distribution of anti-malarial bednets.
Gender and age: | Under-5 children |
---|---|
Total Direct Population: | Unspecified |
Unspecified
Return to topUnspecified
Results achieved as of January 2012 include: ensuring an effective global surveillance system to detect the transmission of polio and guide campaign strategies; providing technical assistance to ensure that the sensitivity of the surveillance system in the key polio affected regions of Africa and Asia is enhanced; monitoring the overall surveillance systems by conducting18 surveillance reviews in 2010,and 20 surveillance reviews in 2011; establishing an effective and accredited laboratory network of 144 labs; establishing environmental sampling sites to collect and test sewage samples to detect the transmission of polio in the environment, especially in high-risk polio-free regions of endemic countries – a total of 11 sites have been established in India, Pakistan, Nigeria and Angola; monitoring and evaluation of routine immunization systems in key polio-affected countries; training and sharing of best practices from the implementation of polio vaccination campaigns; assisting in the delivery of other immunizations including measles vaccines, and in the planning for the introduction of new vaccines against childhood diseases, including pneumonia and diarrhea, and in the conduct of “Child Health Days” in Africa through supplementary immunization activities